Search results

66 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
T cells alone are sufficient to establish and maintain HIV infection in the brain
Led by J. Victor Garcia, PhD, UNC researchers report in the Journal of Clinical Investigation that T cells in the brain may be an important HIV reservoir that should be targeted by HIV cure approaches.
Located in News / 2018 / June
NIH Grant to Provide Doctoral Training to Nicaraguan Researchers
The National Institutes of Health (NIH) has awarded a five-year $1.2-million grant to support training Nicaraguan researchers at UNC and at the University of Nicaragua, León.
Located in Vital Signs / 2018 / May 17
Gopal to be Winter Commencement speaker
Dr. Satish Gopal, an innovative cancer researcher on the forefront of cancer treatment in Malawi, will be the featured speaker at UNC's Winter Commencement ceremony.
Located in News / 2017 / November
Researchers Define Burden of Hepatitis in Democratic Republic of the Congo
Research led by Jonathan Parr, MD, MPH, shows how to adapt an existing HIV testing method to detect hepatitis C virus.
Located in News / 2017 / October
Researchers receive $3.6 million award to improve mental health treatment in Africa
A collaborative, international team at UNC has received a multimillion dollar award to study the mental health of people in Malawi and Tanzania living with a non-communicable disease, like diabetes or hypertension. Non-communicable diseases are the second leading cause of death in Malawi, according to the World Health Organization.
Located in Vital Signs / 2017 / Sept. 28
Ebola Detected in Semen of Survivors Two Years after Infection
Ebola virus RNA can persist in the semen of survivors more than two years after the onset of infection researchers at the University of North Carolina at Chapel Hill have found.
Located in Vital Signs / 2017 / Aug. 3
Vorinostat Renders Dormant HIV Infection Vulnerable to Clearance
The ability for HIV to hide in the body in a dormant state makes curing the 40 million people living with the virus a challenge. Researchers at the University of North Carolina at Chapel Hill have shown the drug Vorinostat reverses this latency, causing resting CD4 T-cells to express HIV.
Located in Vital Signs / 2017 / Aug. 3
UNC to Test Therapeutic Vaccine in People Living with HIV
A multidisciplinary research team at the University of North Carolina at Chapel Hill has been awarded more than $5.6 million from the National Institutes of Health (NIH) to test a therapeutic vaccine in people living with HIV.
Located in Vital Signs / 2017 / July 27
Mending Hearts in Nicaragua
In February, three UNC interventional cardiologists and a team of dedicated health care professionals travelled to Nicaragua to perform a life-saving, minimally invasive procedure on as many patients as they could, and to bring the best in cardiac care to a country without heart surgeons.
Located in News / 2017 / May
Maternal and infant outcomes improve at the University Teaching Hospital in Lusaka, Zambia
The UNC Department of Obstetrics and Gynecology has a long-standing partnership with this hospital.
Located in News / 2017 / April